Shajan Peter
YOU?
Author Swipe
View article: Initial treatment approaches for nodular gastric antral vascular ectasia: A comparison of endoscopic band ligation and thermal therapies
Initial treatment approaches for nodular gastric antral vascular ectasia: A comparison of endoscopic band ligation and thermal therapies Open
BACKGROUND Gastric antral vascular ectasia (GAVE) accounts for up to 4% of nonvariceal upper gastrointestinal bleeding. Argon plasma coagulation and radiofrequency ablation have been primary treatment modalities for patients with linear an…
View article: Unrepaired Tetralogy of Fallot with Pulmonary Atresia and Major Aorto-pulmonary Collateral Arteries in Pregnancy: A Case Report
Unrepaired Tetralogy of Fallot with Pulmonary Atresia and Major Aorto-pulmonary Collateral Arteries in Pregnancy: A Case Report Open
Tetralogy of Fallot with pulmonary atresia and major aortopulmonary collateral arteries (MAPCA) represents the most severe variant of this congenital heart disease, with complete atresia of the pulmonary valve replacing pulmonary stenosis.…
View article: Differential gene expression profiles of pancreatic ductal adenocarcinomas among African American and Caucasian American patients
Differential gene expression profiles of pancreatic ductal adenocarcinomas among African American and Caucasian American patients Open
These findings show distinct gene expression profiles and modulated pathways in AA and CA PDACs, supporting development of race-based therapeutic targets.
View article: Performance of Computer-Aided Detection and Quality of Bowel Preparation: A Comprehensive Analysis of Colonoscopy Outcomes
Performance of Computer-Aided Detection and Quality of Bowel Preparation: A Comprehensive Analysis of Colonoscopy Outcomes Open
Background Artificial intelligence (AI) has emerged as a promising tool for detecting and characterising colorectal polyps during colonoscopy, offering potential enhancements in traditional colonoscopy procedures to improve outcomes in pat…
View article: Lumen‐apposing metal stents provide early and late clinical benefits for the management of benign gastrointestinal strictures: Is there a role for definitive therapy?
Lumen‐apposing metal stents provide early and late clinical benefits for the management of benign gastrointestinal strictures: Is there a role for definitive therapy? Open
Objectives This study aimed to characterize the clinical outcomes, safety, and efficacy of lumen‐apposing metal stents (LAMS) in treating benign gastrointestinal strictures. Methods A single‐center retrospective review of all patients who …
View article: Clinical approach to indeterminate biliary strictures: Clinical presentation, diagnosis, and workup
Clinical approach to indeterminate biliary strictures: Clinical presentation, diagnosis, and workup Open
The liver is one of the organs most commonly involved in metastatic disease, especially due to its unique vascularization. It’s well known that liver metastases represent the most common hepatic malignant tumors. From a practical point of …
View article: Novel Biomarkers and Distinct Transcriptomic Profile of Barrett’s Esophagus Epithelial Stem Cells
Novel Biomarkers and Distinct Transcriptomic Profile of Barrett’s Esophagus Epithelial Stem Cells Open
Barrett’s esophagus, a metaplastic condition that originates in the distal esophagus, is the only known precursor lesion for the development of esophageal adenocarcinoma, which has a devasting 5-year survival rate of <20%. The large number…
View article: Supplementary Figure 1 from BZW2 Inhibition Reduces Colorectal Cancer Growth and Metastasis
Supplementary Figure 1 from BZW2 Inhibition Reduces Colorectal Cancer Growth and Metastasis Open
S1. BZW2 mRNA overexpression in CRC.
View article: Supplementary Figure 3 from BZW2 Inhibition Reduces Colorectal Cancer Growth and Metastasis
Supplementary Figure 3 from BZW2 Inhibition Reduces Colorectal Cancer Growth and Metastasis Open
S3. BZW2-knockdown reduces cell invasion.
View article: Supplementary Figure 7 from BZW2 Inhibition Reduces Colorectal Cancer Growth and Metastasis
Supplementary Figure 7 from BZW2 Inhibition Reduces Colorectal Cancer Growth and Metastasis Open
S7. miR-98-5p regulates BZW2 in CRC cells.
View article: Supplementary Data from BZW2 Inhibition Reduces Colorectal Cancer Growth and Metastasis
Supplementary Data from BZW2 Inhibition Reduces Colorectal Cancer Growth and Metastasis Open
Supplementary figure legends 1-8, and supplementary tables 1-5
View article: Supplementary Figure 3 from BZW2 Inhibition Reduces Colorectal Cancer Growth and Metastasis
Supplementary Figure 3 from BZW2 Inhibition Reduces Colorectal Cancer Growth and Metastasis Open
S3. BZW2-knockdown reduces cell invasion.
View article: Supplementary Figure 2 from BZW2 Inhibition Reduces Colorectal Cancer Growth and Metastasis
Supplementary Figure 2 from BZW2 Inhibition Reduces Colorectal Cancer Growth and Metastasis Open
S2. BZW2 expression in CRC.
View article: Supplementary Figure 5 from BZW2 Inhibition Reduces Colorectal Cancer Growth and Metastasis
Supplementary Figure 5 from BZW2 Inhibition Reduces Colorectal Cancer Growth and Metastasis Open
S5. MALAT1 and NEAT1 are downstream target genes of BZW2 in CRC.
View article: Supplementary Figure 4 from BZW2 Inhibition Reduces Colorectal Cancer Growth and Metastasis
Supplementary Figure 4 from BZW2 Inhibition Reduces Colorectal Cancer Growth and Metastasis Open
S4. BZW2 is involved in CRC tumor growth.
View article: Supplementary Data from BZW2 Inhibition Reduces Colorectal Cancer Growth and Metastasis
Supplementary Data from BZW2 Inhibition Reduces Colorectal Cancer Growth and Metastasis Open
Supplementary figure legends 1-8, and supplementary tables 1-5
View article: Supplementary Figure 2 from BZW2 Inhibition Reduces Colorectal Cancer Growth and Metastasis
Supplementary Figure 2 from BZW2 Inhibition Reduces Colorectal Cancer Growth and Metastasis Open
S2. BZW2 expression in CRC.
View article: Supplementary Figure 8 from BZW2 Inhibition Reduces Colorectal Cancer Growth and Metastasis
Supplementary Figure 8 from BZW2 Inhibition Reduces Colorectal Cancer Growth and Metastasis Open
S8. EZH2 and BZW2 correlation in CRC cells.
View article: Supplementary Figure 1 from BZW2 Inhibition Reduces Colorectal Cancer Growth and Metastasis
Supplementary Figure 1 from BZW2 Inhibition Reduces Colorectal Cancer Growth and Metastasis Open
S1. BZW2 mRNA overexpression in CRC.
View article: Supplementary Figure 4 from BZW2 Inhibition Reduces Colorectal Cancer Growth and Metastasis
Supplementary Figure 4 from BZW2 Inhibition Reduces Colorectal Cancer Growth and Metastasis Open
S4. BZW2 is involved in CRC tumor growth.
View article: Data from BZW2 Inhibition Reduces Colorectal Cancer Growth and Metastasis
Data from BZW2 Inhibition Reduces Colorectal Cancer Growth and Metastasis Open
Because survival of patients with metastatic colorectal cancer remain poor, there is an urgent need to identify potential novel druggable targets that are associated with colorectal cancer progression. One such target, basic leucine zipper…
View article: Supplementary Figure 6 from BZW2 Inhibition Reduces Colorectal Cancer Growth and Metastasis
Supplementary Figure 6 from BZW2 Inhibition Reduces Colorectal Cancer Growth and Metastasis Open
S6. MYC regulates BZW2 in CRC cells.
View article: Supplementary Figure 8 from BZW2 Inhibition Reduces Colorectal Cancer Growth and Metastasis
Supplementary Figure 8 from BZW2 Inhibition Reduces Colorectal Cancer Growth and Metastasis Open
S8. EZH2 and BZW2 correlation in CRC cells.
View article: Supplementary Figure 7 from BZW2 Inhibition Reduces Colorectal Cancer Growth and Metastasis
Supplementary Figure 7 from BZW2 Inhibition Reduces Colorectal Cancer Growth and Metastasis Open
S7. miR-98-5p regulates BZW2 in CRC cells.